vs 7,255 other HR bills in the 110th — cohort avg 47d
Summary
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
Lobbying filings that explicitly cite this bill (50)
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Cited source text, amounts, lobbyists, and targets
HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; potential legislation related to Medicare DMEPOS accreditation and surety bond requirements; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to pedigree and track and trace requirements; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; potential amendments to S. 1693, the "Wired for Health Care Quality Act," re privacy issues; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008"; HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid.
Client expense: $140,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
Cited source text, amounts, lobbyists, and targets
H.R. 1474, Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
S. 1544, Medicare Quality Enhancement Act of 2007
S. 1951, Fair Medicaid Drug Payment Act of 2007
H.R. 3700, Fair Medicaid Drug Payment Act of 2007 H.R. 2770, Legislation to ensure more appropriate payment amounts for drugs and biologics under Part B of the Medicare
program by excluding customary prompt pay discounts.
H.R. 6331, Medicare Improvements for Patients and Providers
S. 3101, Medicare Improvements for Patients and Providers
S. 3118, Preserving Access to Medicare Act of 2008
S. 1954, Pharmacy Access Improvement (PhAIm) Act of 2007
H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008
Client expense: $180,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Issues pertaining to implementation of the Medicare Prescription drug benefit
HR.1474, Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
S.1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007
S.1954, Pharmacy Access Improvement (PhAIm) Act of 2007 S.1951, Fair Medicaid Drug Payment Act of 2007
HR.3700, Fair Medicaid Drug Payment Act of 2007
HR.3140, Saving Our Community Pharmacies Act of 2007
S.3101, Medicare Improvements for Patients and Providers Act of 2008
S.3118, Preserving Access to Medicare Act of 2008
HR.6331, Medicare Improvements for Patients and Providers Act of 2008
S.2408, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007
HR.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007
Client expense: Not reported · Firm income: $50,000
Cited source text, amounts, lobbyists, and targets
See Addendum HR 971 and S 885 / S 2161- Community Pharmacy Fairness Act of 2007
HR 6353 and S. 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007
HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
HR 3140 - Saving Our Community Pharmacies Act of 2007
HR 3090 - Patient and Pharmacy Protection Act of 2007
HR 3193 Access to Community Pharmacy Preservation Act of 2007
S 596 - Safe Internet Pharmacy Act of 2007
S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007
S 2161 - Community Pharmacy Fairness Act of 2007
S 877 - Controlling the Abuse of Prescription Act of 2007
Client expense: $314,868 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Issues related to drug coverage including pharmacy payments, reimbursement, competition and plan administration;
Health Information Technology with respect to data privacy and electronic prescribing of prescription drugs;
Promotion of competition in the prescription drug marketplace including the drug approval process;
Additional Issues - see addendum Issues related to drug coverage including pharmacy payments, reimbursement, competition and plan administration
HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007;
HR 3140 - Saving Our Community Pharmacies Act of 2007
HR 3193 - Access to Community Pharmacy Preservation Act of 2007
S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007
S 2161 - Community Pharmacy Fairness Act of 2007
Health information technology with respect to data privacy and electronic prescribing of prescription drugs
HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007
HR 3800 - Promoting Health Information Technology Act
HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008
HR 6898 - Health e-Information Technology Act
S 1408 - Health Information Technology Act of 2007
S 1693 - Wired for Health Care Quality Act
S. 1814 - Health Information Privacy and Security Act
Promotion of competition in the prescription drug marketplace including the drug approval process
HR 1432 and S. 316 - Preserve Access to Affordable Generics Act
HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007
HR 5629 - Pathway for Biosimilars Act
S 28 - Generics First Act of 2007
S 1695 - Biologics Price Competition and Innovation Act of 2007
HR 1038 / S 623 - Access to Life-Saving Medicine Act
S 316 Preserve Access to Affordable Generics Act
HR 1505 / S 1695 Affordable Biologics for Consumers Act
HR 5629 - Pathway for Biosimilars Act
Additional Issues
HR 5683 - Government Accountability Office Act of 2008
S 1507 - Access to Medicare Data Act of 2007
S 273 - Prescription Drug and Health Improvement Act of 2007
HR 3610 - Food and Drug Import Safety Act of 2007
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office
Client expense: $314,868 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
H.R.4312, To amend the Internal Revenue Code of 1986 to extend certain benefits applicable to the Gulf Opportunity Zone, and for other purposes, Pipeline infrastructure related issues.
H.R.6899, Comprehensive American Energy Security and Consumer Protection Act, Natural gas pipeline infrastructure issues.
H.R.1474, Emergency Economic Stabilization Act, Corporate tax related issues. H.R.2230, To prevent certain discriminatory taxation of natural gas pipeline property, Natural gas pipeline tax related issues.
Client expense: Not reported · Firm income: $40,000
Cited source text, amounts, lobbyists, and targets
H.R.970, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan.
H.R.971, the Community Pharmacy Fairness Act, as related to provider negotiations in the Medicare program.
H.R.1424, the Emergency Economic Stabilization Act of 2008, as related to fiscal sustainablity of healthcare services. H.R.1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act, as related to provider reimbursement in the Medicare program.
H.R.3700, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program.
H.R.5613, Protecting the Medicaid Safety Net Act of 2008, as related to provider participation in the Medicaid program.
H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, as related to drug safety and electronic tracking of pharmaceuticals.
H.R.6353/S.980, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies.
H.R.6357, PRO(TECH)T Act of 2008, as related to pharmacy involvement in health information technology.
H.R. 6898, the Health-e Information Technology Act of 2008 as related to pharmacy involvement in health information technology
H.R. 7110, the Job Creation and Unemployment Relief Act of 2008, as related to increased funding for state Medicaid programs.
S.484, the Enhancing Drug Safety and Innovation Act, all provisions related to the safety of prescription medicines.
S. 1276, the Methamphetamine Production Prevention Act as related to recordkeeping requirements for pharmacies.
S.1693, Wired for Health Care Quality Act, as related to health information technology.
S.1827, Pharmacists Access and Recognition in Medicare (PhARM) Act, as related to provider participation in the Medicare program.
S.1915, Electronic Prescribing Drug Act, as related to the regulation of electronic prescribing of pharmaceuticals.
S.1951, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program.
S.1954, Pharmacy Access Improvement (PhAIm) Act, as related to access standards to pharmacies.
S.2013/H.R.390, Patient and Pharmacy Protection Act, as related to prescription requirements in the Medicaid program.
S.2071, Combat Methamphetamine Enhancement Act, as related to the distribution of legal substances used in the production of methamphetamine.
S.2274, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan.
S.2408/H.R.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007, as related to electronic health care in the Medicare program.
S.3101/H.R.6331, Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement in the Medicaid and Medicare programs and electronic health care.
Various issues related to the disposal of prescription drugs and drug Take Back programs, no specific legislation
Client expense: $320,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Consumer Product Safety Commission (CPSC), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
H.R. 1474, Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
S. 1544, Medicare Quality Enhancement Act of 2007
S. 1951, Fair Medicaid Drug Payment Act of 2007
H.R. 3700, Fair Medicaid Drug Payment Act of 2007 H.R. 2770, Legislation to ensure more appropriate payment amounts for drugs and biologics under Part B of the Medicare program by excluding customary prompt pay discounts.
H.R. 6331, Medicare Improvements for Patients and Providers
S. 3101, Medicare Improvements for Patients and Providers
S. 3118, Preserving Access to Medicare Act of 2008
S. 1954, Pharmacy Access Improvement (PhAIm) Act of 2007
H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008
Client expense: Not reported · Firm income: $10,000
Cited source text, amounts, lobbyists, and targets
H.R. 1474, Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
S. 1544, Medicare Quality Enhancement Act of 2007
S. 1951, Fair Medicaid Drug Payment Act of 2007
H.R. 3700, Fair Medicaid Drug Payment Act of 2007 H.R. 2770, Legislation to ensure more appropriate payment amounts for drugs and biologics under Part B of the Medicare
program by excluding customary prompt pay discounts.
H.R. 6331, Medicare Improvements for Patients and Providers
S. 3101, Medicare Improvements for Patients and Providers
S. 3118, Preserving Access to Medicare Act of 2008
S. 1954, Pharmacy Access Improvement (PhAIm) Act of 2007
H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008
Client expense: $205,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Issues related to drug coverage including pharmacy payments, reimbursement, competition and plan administration;
Health Information Technology with respect to data privacy and electronic prescribing of prescription drugs;
Promotion of competition in the prescription drug marketplace including the drug approval process;
Additional Issues - see addendum Issues related to drug coverage including pharmacy payments, reimbursement, competition and plan administration
HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007;
HR 3140 - Saving Our Community Pharmacies Act of 2007
HR 3193 - Access to Community Pharmacy Preservation Act of 2007
S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007
S 2161 - Community Pharmacy Fairness Act of 2007
Health information technology with respect to data privacy and electronic prescribing of prescription drugs
HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007
HR 3800 - Promoting Health Information Technology Act
HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008
HR 6898 - Health e-Information Technology Act
S 1408 - Health Information Technology Act of 2007
S 1693 - Wired for Health Care Quality Act
S. 1814 - Health Information Privacy and Security Act
Promotion of competition in the prescription drug marketplace including the drug approval process
HR 1432 and S. 316 - Preserve Access to Affordable Generics Act
HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007
HR 5629 - Pathway for Biosimilars Act
S 28 - Generics First Act of 2007
S 1695 - Biologics Price Competition and Innovation Act of 2007
HR 1038 / S 623 - Access to Life-Saving Medicine Act
S 316 Preserve Access to Affordable Generics Act
HR 1505 / S 1695 Affordable Biologics for Consumers Act
HR 5629 - Pathway for Biosimilars Act
Additional Issues
HR 5683 - Government Accountability Office Act of 2008
S 1507 - Access to Medicare Data Act of 2007
S 273 - Prescription Drug and Health Improvement Act of 2007
HR 3610 - Food and Drug Import Safety Act of 2007
Client expense: $324,944 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
See Addendum HR 971 and S 885 / S 2161- Community Pharmacy Fairness Act of 2007
HR 6353 and S. 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007
HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
HR 3140 - Saving Our Community Pharmacies Act of 2007
HR 3090 - Patient and Pharmacy Protection Act of 2007
HR 3193 Access to Community Pharmacy Preservation Act of 2007
S 596 - Safe Internet Pharmacy Act of 2007
S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007
S 2161 - Community Pharmacy Fairness Act of 2007
S 877 - Controlling the Abuse of Prescription Act of 2007
Client expense: $324,944 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
Health Information Technology
S.1693: Wired for Health Care Quality Act
H.R. 6357: PRO(TECH)T Act of 2008
H.R. 6898: Health-e Information Technology Act of 2008
Anti-trust
H.R.971/S.2161: Community Pharmacy Fairness Act Pharmacy Reimbursement
H.R.1474: Fair and Speedy Treatment of Medicare Drug Claims Act
S.1954: Pharmacy Access Improvement Act of 2007
H.R. 6353: Ryan Haight Online Pharmacy Consumer Protection Act of 2008
Client expense: Not reported · Firm income: $80,000
Cited source text, amounts, lobbyists, and targets
Health Information Technology
S.1693: Wired for Health Care Quality Act
H.R. 6357: PRO(TECH)T Act of 2008
H.R. 6898: Health-e Information Technology Act of 2008
Anti-trust
H.R.971/S.2161: Community Pharmacy Fairness Act Pharmacy Reimbursement
H.R.1474: Fair and Speedy Treatment of Medicare Drug Claims Act
S.1954: Pharmacy Access Improvement Act of 2007
H.R. 6353: Ryan Haight Online Pharmacy Consumer Protection Act of 2008
Client expense: Not reported · Firm income: $80,000
Cited source text, amounts, lobbyists, and targets
Issues related to pharmacy payments, the Medicare Part D and competitive bidding.
H.R. 1474, Fair and Speedy Treatment (FAST) Act
S. 1827, Pharmacist Access and Recognition in Medicare Act of 2007
S. 1954, Pharmacy Access Improvement PhAIm) Act of 2007 S. 1951, Fair Medicaid Drug Payment Act of 2007
HR 3700, Fair Medicaid Drug Payment Act of 2007
HR 3140, Saving Our Community Pharmacies Act of 2007
S 3101 and HR 6331 the Medicare Improvements for Patients Providers Act of 2008
HR 6252, Medicare DMEPOS Competitive Acquisition Reform Act of 2008
S. 3144, Medicare DMEPOS Competitive Acquisition Reform Act of 2008
S 3118, Preserving Access to Medicare Act of 2008
Client expense: $1,316,532 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Cited source text, amounts, lobbyists, and targets
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy; HR 6852, the "Small Business Cooperative for Health Care Options to Improve Coverage for Employees (CHOICE) Act of 2008; S. 1693, the "Wired for Health Care Quality Act," particularly Sec. 401; S. 980, the "Ryan Haight Online Pharmacy Consumer Protection Act of 2008";
II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Providers Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid,
all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Client expense: $150,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE
Cited source text, amounts, lobbyists, and targets
Issues pertaining to implementation of the Medicare Prescription drug benefit
HR.1474, Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
S.1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007
S.1954, Pharmacy Access Improvement (PhAIm) Act of 2007 S.1951, Fair Medicaid Drug Payment Act of 2007
HR.3700, Fair Medicaid Drug Payment Act of 2007
HR.3140, Saving Our Community Pharmacies Act of 2007
S.3101, Medicare Improvements for Patients and Providers Act of 2008
S.3118, Preserving Access to Medicare Act of 2008
HR.6331, Medicare Improvements for Patients and Providers Act of 2008
S.2408, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007
HR.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007
Client expense: Not reported · Firm income: $50,000
Cited source text, amounts, lobbyists, and targets
H.R. 1474, Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
S. 1544, Medicare Quality Enhancement Act of 2007
S. 1951, Fair Medicaid Drug Payment Act of 2007
H.R. 3700, Fair Medicaid Drug Payment Act of 2007 H.R. 2770, Legislation to ensure more appropriate payment amounts for drugs and biologics under Part B of the Medicare program by excluding customary prompt pay discounts.
H.R. 6331, Medicare Improvements for Patients and Providers
S. 3101, Medicare Improvements for Patients and Providers
S. 3118, Preserving Access to Medicare Act of 2008
S. 1954, Pharmacy Access Improvement (PhAIm) Act of 2007
H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008
Client expense: Not reported · Firm income: $30,000
Cited source text, amounts, lobbyists, and targets
See addendum. H.R.970, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan.
H.R.971, the Community Pharmacy Fairness Act, as related to provider negotiations in the Medicare program.
H.R.1108, Family Smoking Prevention and Tobacco Control Act, as related to the regulation of the sale of tobacco products.
H.R.1424, the Emergency Economic Stabilization Act of 2008, as related to fiscal sustainablity for healthcare services.
H.R.1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act, as related to provider reimbursement in the Medicare program.
H.R.3700, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program.
H.R.4008, Credit and Debit Card Receipt Clarification Act of 2007, as related to fair credit card practices.
H.R.5491, Emilys Act, as related to the certification of pharmacy technicians.
H.R.5546, Credit Card Fair Fee Act of 2008, as related to fair credit card practices.
H.R.5613, Protecting the Medicaid Safety Net Act of 2008, as related to provider participation in the Medicaid program.
H.R.5658, Duncan Hunter National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program.
H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, as related to drug safety and electronic tracking of pharmaceuticals.
H.R.6353/S.980, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies.
H.R.6357, PRO(TECH)T Act of 2008, as related to pharmacy involvement in health information technology.
H.R. 6491/S.3434, the Organized Retail Crime Act of 2008, as related to the prosecution of organized theft.
H.R. 6713, the E-Fencing Enforcement Act of 2008, as related to the prosecution of organized theft.
H.R. 6831/S.3666, the Copper Theft Prevention Act of 2008 as related to theft and interstate fencing of stolen copper.
H.R. 6898, the Health-e Information Technology Act of 2008 as related to pharmacy involvement in health information technology
H.R. 7110, the Job Creation and Unemployment Relief Act of 2008, as related to increased funding for state Medicaid programs.
S.484, the Enhancing Drug Safety and Innovation Act, all provisions related to the safety of prescription medicines.
S. 1276, the Methamphetamine Production Prevention Act as related to recordkeeping requirements for pharmacies.
S.1693, Wired for Health Care Quality Act, as related to health information technology.
S.1827, Pharmacists Access and Recognition in Medicare (PhARM) Act, as related to provider participation in the Medicare program.
S.1915, Electronic Prescribing Drug Act, as related to the regulation of electronic prescribing of pharmaceuticals.
S.1951, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program.
S.1954, Pharmacy Access Improvement (PhAIm) Act, as related to access standards to pharmacies.
S.2013/H.R.390, Patient and Pharmacy Protection Act, as related to prescription requirements in the Medicaid program.
S.2071, Combat Methamphetamine Enhancement Act, as related to the distribution of legal substances used in the production of methamphetamine.
S.2274, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan.
S.2408/H.R.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007, as related to electronic health care in the Medicare program.
S.2978, Credit and Debit Card Receipt Clarification Act of 2008, as related to fair credit card practices
S.3001, National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program.
S.3086, Credit Card Fair Fee Act of 2008, as related to fair credit card practices.
S.3101/H.R.6331, Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement in the Medicaid and Medicare programs and electronic health care.
Client expense: $300,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), President of the U.S., SENATE
Cited source text, amounts, lobbyists, and targets
Medicare Part D: prompt pay/EFT for pharmacies (HR 1474/S 1827/S 1954/HR 6331), Changes to the part D benefit (HR 3162/S 2499/HR 6331), Electronic prescribing and eRx for controlled substances (HR 4296/S 2408/HR 6331), access to Medicare Data (HR 6388/S 1507/HR 6331), various regulatory issues related to Part D benefit. Medicare Part B: Changes to the competitive acquisition program for biologics (HR 3162) and prompt pay exclusion for distribution (HR 2770); AMP changes (HR 6331)
Client expense: $240,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), Office of Management & Budget (OMB), SENATE
Cited source text, amounts, lobbyists, and targets
Health Information Technology, Electronic Prescribing, Inappropriate use of Human Growth Hormone, Comparative Effectiveness, 340B Program, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Internet Pharmacies, Carve-out of Generic Drugs from State Generic Substitution Laws HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects
HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects
HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects
HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects
HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects
HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects
HR 2914 - Medicare IVIG Access Act of 2007; all aspects
HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects
HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects
HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects
HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects
HR 3800 - Promoting Health Information Technology Act; all aspects
HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects
HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects
HR 5629 - Pathway for Biosimilars Act; all aspects
HR 5683 - Government Accountability Office Act of 2008, section 721
HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008; all aspects
HR 6898 - Health e-Information Technology Act; all aspects
S 28 - Generics First Act of 2007; all aspects
S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects
S 251 - Pharmaceutical Market Access Act of 2007; all aspects
S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects
S 596 - Safe Internet Pharmacy Act of 2007; section 511(c)
S 976 - Genomics and Personalized Medicine Act of 2007; all aspects
S 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects
S 1408 - Health Information Technology Act of 2007; all aspects
S 1507 - Access to Medicare Data Act of 2007; all aspects
S 1693 - Wired for Health Care Quality Act; all aspects
S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects
S. 1814 - Health Information Privacy and Security Act; all aspects
S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects
S 2161 - Community Pharmacy Fairness Act of 2007; all aspects
Client expense: $434,097 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Cited source text, amounts, lobbyists, and targets
Electronic Prescribing, Rule for Calculating Average Manufacturing Price for Prescription Drugs, Pharmacy Payments, Antitrust Exemption for Independent Pharmacies, Internet Pharmacies, Electronic Prescribing of Controlled Substances HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects
HR 6353 and S. 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects
HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects
HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects
HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects
HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects
HR 3193 Access to Community Pharmacy Preservation Act of 2007; all aspects
S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects
S 251 - Pharmaceutical Market Access Act of 2007; all aspects
S 596 - Safe Internet Pharmacy Act of 2007; section 511(c)
S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects
S 2161 - Community Pharmacy Fairness Act of 2007; all aspects
Client expense: $434,097 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Cited source text, amounts, lobbyists, and targets
H.R.4312, To amend the Internal Revenue Code of 1986 to extend certain benefits applicable to the Gulf Opportunity Zone, and for other purposes, Pipeline infrastructure related issues.
H.R.6899, Comprehensive American Energy Security and Consumer Protection Act, Natural gas pipeline infrastructure issues.
H.R.1474, Emergency Economic Stabilization Act, Corporate tax related issues. H.R.2230, To prevent certain discriminatory taxation of natural gas pipeline property, Natural gas pipeline tax related issues.
Client expense: Not reported · Firm income: $40,000
Cited source text, amounts, lobbyists, and targets
HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects
HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects
HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects
HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects
HR 2914 - Medicare IVIG Access Act of 2007; all aspects
HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects
HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects
HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects
HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects
HR 3800 - Promoting Health Information Technology Act; all aspects
HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects
HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects
HR 5629 - Pathway for Biosimilars Act; all aspects
HR 5683 - Government Accountability Office Act of 2008, section 721
HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008; all aspects
HR 6898 - Health e-Information Technology Act; all aspects
S 28 - Generics First Act of 2007; all aspects
S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects
S 251 - Pharmaceutical Market Access Act of 2007; all aspects
S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects
S 596 - Safe Internet Pharmacy Act of 2007; section 511(c)
S 976 - Genomics and Personalized Medicine Act of 2007; all aspects
S 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects
S 1408 - Health Information Technology Act of 2007; all aspects
S 1507 - Access to Medicare Data Act of 2007; all aspects
S 1693 - Wired for Health Care Quality Act; all aspects
S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects
S. 1814 - Health Information Privacy and Security Act; all aspects
S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects
S 2161 - Community Pharmacy Fairness Act of 2007; all aspects
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
Cited source text, amounts, lobbyists, and targets
HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects
HR 6353 and S. 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects
HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects
HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects
HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects
HR 3193 Access to Community Pharmacy Preservation Act of 2007; all aspects
S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects
S 251 - Pharmaceutical Market Access Act of 2007; all aspects
S 596 - Safe Internet Pharmacy Act of 2007; section 511(c)
S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects
S 2161 - Community Pharmacy Fairness Act of 2007; all as
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Medicare Payment Advisory Commission (MedPAC), SENATE
Cited source text, amounts, lobbyists, and targets
H.R. 1474, Fair and Speedy Treatment (FAST) Act; S. 1827, Pharmacist Access and Recognition in Medicare Act of 2007; S. 3162, Children's Health and Medicare Protection Act of 2007; S. 2499, Medicare, Medicaid and SCHIP Extension Act of 2007; HR 976, Children's Health Insurance Program Reauthorization Act of 2007; S. 1954, Pharmacy Access Improvement PhAIm) Act of 2007; S. 1951, Fair Medicaid Drug Payment Act of 2007 HR 3700, Fair Medicaid Drug Payment Act of 2007
HR 3140, Saving Our Community Pharmacies Act of 2007
HR 3101 and HR 6331 the Medicare Improvements for Patients Providers Act of 2008
HR 6252 Medicare DMEPOS Competitive Acquisition Reform Act of 2008
S. 3144 Medicare DMEPOS Competitive Acquisition Reform Act of 2008
Client expense: $1,010,101 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
Cited source text, amounts, lobbyists, and targets
HR 971 and S 885 Community Pharmacy Fairness Act of 2007
HR 1474 Fair and Speedy Treatment of Medicare Prescription Drug Claims Act of 2007
HR 2970 Pharmacy Benefit Manager Transparency Act of 2007
HR 3140 Saving Our Community Pharmacies Act of 2007 HR 3090 Patient and Pharmacy Protection Act of 2007
HR 3193 Access to Community Pharmacy Preservation Act of 2007
HR 3932 Medicare Prescription Drug Savings and Choice Act of 2007
S 242 Pharmaceutical Market Access and Drug Safety Act of 2007
S 251 Pharmaceutical Market Access Act of 2007
S 273 Prescription Drug and Health Improvement Act of 2007
S 1954 Pharmacy Access Improvement Act of 2007
S 2161 Community Pharmacy Fairness Act of 2007
Client expense: Not reported · Firm income: $20,000
Cited source text, amounts, lobbyists, and targets
HR 971 and S 885 Community Pharmacy Fairness Act of 2007
HR 1474 Fair and Speedy Treatment of Medicare Prescription Drug Claims Act of 2007
HR 2970 Pharmacy Benefit Manager Transparency Act of 2007
HR 3140 Saving Our Community Pharmacies Act of 2007 HR 3090 Patient and Pharmacy Protection Act of 2007
HR 3193 Access to Community Pharmacy Preservation Act of 2007
S 242 Pharmaceutical Maraket Access and Drug Safety Act of 2007
S 251 Pharmaceutical Market Access Act of 2007
S 1954 Pharmacy Access Improvement Act of 2007
S 2161 Community Pharmacy Fairness Act of 2007
Client expense: Not reported · Firm income: $20,000
Cited source text, amounts, lobbyists, and targets
H.R. 1474, Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
S. 1544, Medicare Quality Enhancement Act of 2007
S. 1951, Fair Medicaid Drug Payment Act of 2007
H.R. 3700, Fair Medicaid Drug Payment Act of 2007 H.R. 2770, Legislation to ensure more appropriate payment amounts for drugs and biologics under Part B of the Medicare
program by excluding customary prompt pay discounts.
H.R. 6331, Medicare Improvements for Patients and Providers
S. 3101, Medicare Improvements for Patients and Providers
S. 3118, Preserving Access to Medicare Act of 2008
S. 1954, Pharmacy Access Improvement (PhAIm) Act of 2007
Client expense: $205,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Issues pertaining to implementation of the Medicare Prescription drug benefit
HR.1474, Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
S.1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007
HR.3162, Children's Health and Medicare Protection Act of 2007 S.1954, Pharmacy Access Improvement (PhAIm) Act of 2007
S.1951, Fair Medicaid Drug Payment Act of 2007
HR.3700, Fair Medicaid Drug Payment Act of 2007
HR.3140, Saving Our Community Pharmacies Act of 2007
S.3101, Medicare Improvements for Patients and Providers Act of 2008
S.3118, Preserving Access to Medicare Act of 2008
HR.6331, Medicare Improvements for Patients and Providers Act of 2008
Client expense: Not reported · Firm income: $50,000
Cited source text, amounts, lobbyists, and targets
H.R. 1474, Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
S. 1544, Medicare Quality Enhancement Act of 2007
S. 1951, Fair Medicaid Drug Payment Act of 2007
H.R. 3700, Fair Medicaid Drug Payment Act of 2007 H.R. 2770, Legislation to ensure more appropriate payment amounts for drugs and biologics under Part B of the Medicare program by excluding customary prompt pay discounts.
H.R. 6331, Medicare Improvements for Patients and Providers
S. 3101, Medicare Improvements for Patients and Providers
S. 3118, Preserving Access to Medicare Act of 2008
S. 1954, Pharmacy Access Improvement (PhAIm) Act of 2007
Client expense: Not reported · Firm income: $30,000
Cited source text, amounts, lobbyists, and targets
Electronic Prescribing, Rule for Calculating Average Manufacturing Price for Prescription Drugs, Pharmacy Payments, Antitrust Exemption for Independent Pharmacies, Internet Pharmacies, Electronic Prescribing of Controlled Substances HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects
HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects
HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects
HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects
HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects
HR 3193 Access to Community Pharmacy Preservation Act of 2007; all aspects
S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects
S 251 - Pharmaceutical Market Access Act of 2007; all aspects
S 596 - Safe Internet Pharmacy Act of 2007; section 511(c)
S 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects
S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects
S 2161 - Community Pharmacy Fairness Act of 2007; all aspects
Client expense: $508,492 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE
Cited source text, amounts, lobbyists, and targets
Health Information Technology, Electronic Prescribing, Genetic Nondiscrimination, Inappropriate use of Human Growth Hormone, Medicare Part D Contract Disclsoure Requirements, Comparative Effectiveness, 340B Program, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Internet Pharmacies, Off-Label Use of Prescription Drugs, Over-the-Counter Drug Dispersement, Carve-out of Generic Drugs from State Medicaid Generic Substitution Laws HR 493 and S 358 - Genetic Information Nondiscrimination Act of 2008; Title I
HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects
HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects
HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects
HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects
HR 2567 and S 870 - Medicare Home Infusion Therapy Coverage Act of 2007; all aspects
HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects
HR 2914 - Medicare IVIG Access Act of 2007; all aspects
HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects
HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects
HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects
HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects
HR 3800 - Promoting Health Information Technology Act; all aspects
HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects
HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects
HR 5629 - Pathway for Biosimilars Act; all aspects
HR 5683 - Government Accountability Office Act of 2008, section 721
HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008; all aspects
S 28 - Generics First Act of 2007; all aspects
S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects
S 251 - Pharmaceutical Market Access Act of 2007; all aspects
S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects
S 596 - Safe Internet Pharmacy Act of 2007; section 511(c)
S 976 - Genomics and Personalized Medicine Act of 2007; all aspects
S 980 - Ryan Haight Online Pharmacy Consumer Protection Act of 2007; all aspects
S 1408 - Health Information Technology Act of 2007; all aspects
S 1507 - Access to Medicare Data Act of 2007; all aspects
S 1693 - Wired for Health Care Quality Act; all aspects
S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects
S. 1814 - Health Information Privacy and Security Act; all aspects
S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects
S 2161 - Community Pharmacy Fairness Act of 2007; all aspects
Client expense: $508,492 · Firm income: Not reported
Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE
Cited source text, amounts, lobbyists, and targets
Medicare Part D: prompt pay/EFT for pharmacies (HR 1474/S 1827/ S 1954/HR 6331), changes to the Part D benefit (HR 3162/S 2499/HR 6331), electronic prescribing (H.R. 4296/S 2408/ HR 6331), Access to Medicare Data (H.R. 6388/S 1507), various regulatory issues related to implementing the Medicare Part D benefit.
Medicare Part B: Changes to the competitive acquisition program (HR 3162); prompt pay exculsion from Part B (HR 2770) Items related to the definition of Medicaid Average Manufacture Price (AMP) as espoused by the 2005 Deficit Reduction Act. (HR 3700/HR 6331)
Client expense: $210,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Labor, Dept of (DOL), Medicare Payment Advisory Commission (MedPAC), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
I. HR 971, the "Community Pharmacy Fairness Act of 2007"; S. 2161, the "Community Pharmacy Fairness Act of 2007"; CMS-2238-P, CMS-2238-FC and CMS-2238-IFC, the proposed, final rule, and interim final rule re implementation the Medicaid provisions of the Deficit Reduction Act of 2005; CMS-1270F, Final rule implementing the competitive acquisition program requirements for Durable Medical Equipment Prosthetics, Orthotics and Supplies; HR 2900, provision related to pedigree requirements; HR 4 and S.3, the "Medicare Prescription Drug Price Negotiation Act of 2007"; potential language not included in S. 2499, the "Medicare, Medicaid and SCHIP Extension Act of 2007" re e-prescribing; HR 1474, the "Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; CMS-6006-P, proposed rule requring a surety bond for all Medicare DMEPOS providers; Sec. 913 of FDAAA of 2007, relating to development of a standard numerical drug identifier; and HR 5839, the "Safeguarding America's Pharmaceuticals Act of 2008," provisions relating to imposition of pedigree and track and trace requirements upon community pharmacy;
II. and also HR 3140, "Saving Our Community Pharmacies Act of 2007"; S. 1951, the "Fair Medicaid Drug Payment Act of 2007"; S. 1954, the "Pharmacy Access Improvement (PhAIm) Act of 2007"; HR 3700, the "Fair Medicaid Drug Payment Act of 2007"; Sec. 7002(b) of HR 2006 and PL 110-28, "Requirements for Use of Tamper-Resistant Prescription Pads Under the Medicaid Program", (the U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act of 2007); PL 110-181 -- HR 1585, HR 4986 and S. 1547, National Defense Authorization Act for Fiscal Year 2008, provisions related to pharmacy payment - sections 703 and 702 of HR 1585 and HR 4986 and Sec. 701 of S. 1547, HR 6357, the "PRO(TECH)T Act of 2008", provisions impacting health technology requirements for pharmacies; HR 6331, the "Medicare Improvements for Patients and Prviders Act of 2008," Sec. 154 related to Medicare DMEPOS competitive acquisition program, Sec. 171 related to prompt payment of Part D reimbursements to pharmacies, Sec. 203, related to pharmacy reimbursement under Medicaid,
all of II. done separately and as joint project with the National Association of Chain Drug Stores for the Coalition for Community Pharmacy Action.
Client expense: $180,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
Health Information Technology
S.1693: Wired for Health Care Quality Act
Anti-trust
H.R.971/S.2161: Community Pharmacy Fairness Act
Pharmacy Reimbursement
H.R.1474: Fair and Speedy Treatment of Medicare Drug Claims Act S.1954: Pharmacy Access Improvement Act of 2007
Client expense: Not reported · Firm income: $80,000
Cited source text, amounts, lobbyists, and targets
See addendum. H.R.970, the Dextromethorphan Distribution Act, as related to the abuse of dextromethorphan.
H.R.971, the Community Pharmacy Fairness Act, as related to provider negotiations in the Medicare program.
H.R.1038/S.623, Access to Life-Saving Medicine Act, as related to the approval of generic biopharmaceuticals.
H.R.1108, Family Smoking Prevention and Tobacco Control Act, as related to the regulation of the sale of tobacco products.
H.R.1474, the Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act, as related to provider reimbursement in the Medicare program.
H.R.3140, Saving Our Community Pharmacies Act, as related to Medicaid provider reimbursement.
H.R.3193, Access to Community Pharmacy Preservation Act, as related to Medicaid provider reimbursement.
H.R.3700, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program.
H.R.4008, Credit and Debit Card Receipt Clarification Act of 2007, as related to fair credit card practices.
H.R.5491, Emilys Act, as related to the certification of pharmacy technicians.
H.R.5546, Credit Card Fair Fee Act of 2008, as related to fair credit card practices.
H.R.5613, Protecting the Medicaid Safety Net Act of 2008, as related to provider participation in the Medicaid program.
H.R.5629, Pathway for Biosimilars Act, as related to the availability of generic pharmaceuticals.
H.R.5658, Duncan Hunter National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program.
H.R.5839, Safeguarding America's Pharmaceuticals Act of 2008, as related to drug safety and electronic tracking of pharmaceuticals.
H.R.6252, Medicare DMEPOS Competitive Acquisition Reform Act of 2008, as related to provider participation in the Medicare competitive bidding program.
H.R.6331, the Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement, electronic health care, and Medicare programs.
H.R.6353, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies.
H.R.6357, PRO(TECH)T Act of 2008, as related to health information technology.
S.484, the Enhancing Drug Safety and Innovation Act, all provisions related to the safety of prescription medicines.
S.980, Ryan Haight Online Pharmacy Consumer Protection Act of 2008, as related to online pharmacies.
S.1693, Wired for Health Care Quality Act, as related to health information technology.
S.1695, the Biologics Price Competition and Innovation Act, as related to the approval of generic biopharmaceuticals.
S.1827, Pharmacists Access and Recognition in Medicare (PhARM) Act, as related to provider participation in the Medicare program.
S.1915, Electronic Prescribing Drug Act, as related to the regulation of electronic prescribing of pharmaceuticals.
S.1951, the Fair Medicaid Drug Payment Act, as related to pharmacy reimbursement in the Medicaid program.
S.1954, Pharmacy Access Improvement (PhAIm) Act, as related to access standards to pharmacies.
S.2013/H.R.390, Patient and Pharmacy Protection Act, as related to prescription requirements in the Medicaid program.
S.2071, Combat Methamphetamine Enhancement Act, as related to the distributio of legal substances used in the production of methamphetamine.
S.2274, Dextromethorphan Abuse Reduction Act, as related to the abuse of dextromethorphan.
S.2408/H.R.4296, Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007, as related to electronic health care in the Medicare program.
S.2978, Credit and Debit Card Receipt Clarification Act of 2008, as related to fair credit card practices
S.3001, National Defense Authorization Act for Fiscal Year 2009, as related to provider participation in the TRICARE program.
S.3086, Credit Card Fair Fee Act of 2008, as related to fair credit card practices.
S.3101, Medicare Improvements for Patients and Providers Act of 2008, as related to pharmacy reimbursement and electronic health care.
Client expense: $420,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Natl Drug Control Policy (NDCP), President of the U.S., SENATE
Cited source text, amounts, lobbyists, and targets
HR 493 and S 358 - Genetic Information Nondiscrimination Act of 2007; Title I
HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects
HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects
HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects
HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects
HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects
HR 2914 - Medicare IVIG Access Act of 2007; all aspects
HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects
HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects
HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects
HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects
HR 3800 - Promoting Health Information Technology Act; all aspects
HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects
HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects
HR 5629 - Pathway for Biosimilars Act; all aspects
HR 5683 - Government Accountability Office Act of 2008, section 721
HR 6357 - Protecting Records, Optimizing Treatment, and Easing Communication through Healthcare Technology Act of 2008 or the PRO(TECH) Act of 2008; all aspects
S 28 - Generics First Act of 2007; all aspects
S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects
S 251 - Pharmaceutical Market Access Act of 2007; all aspects
S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects
S 596 - Safe Internet Pharmacy Act of 2007; section 511(c); all aspects
S 976 - Genomics and Personalized Medicine Act of 2007; all aspects
S 980 - Online Pharmacy Consumer Protection Act of 2007; all aspects
S 1408 - Health Information Technology Act of 2007; all aspects
S 1507 - Access to Medicare Data Act of 2007; all aspects
S 1693 - Wired for Health Care Quality Act; all aspects
S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects
S. 1814 - Health Information Privacy and Security Act; all aspects
S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects
S 2161 - Community Pharmacy Fairness Act of 2007; all aspects
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects
HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects
HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects
HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects
HR 3193 Access to Community Pharmacy Preservation Act of 2007; all aspects
S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects
S 251 - Pharmaceutical Market Access Act of 2007; all aspects
S 596 - Safe Internet Pharmacy Act of 2007; section 511(c)
S 980 - Online Pharmacy Consumer Protection Act of 2007; all aspects
S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects
S 2161 - Community Pharmacy Fairness Act of 2007; all aspects
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
Health information technology, Electronic prescribing, Genetic Nondiscrimination, Inappropriate Use of Human Growth Hormone, Contract Disclosure Regulations, Comparative Effectiveness, 340B Program, Confidentiality of Health Information, Generic Drugs, Generic Biologics, Internet Pharmacies, Off-label Use of Prescription Drugs HR 493 and S 358 - Genetic Information Nondiscrimination Act of 2007; Title I
HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects
HR 1432 and S. 316 - Preserve Access to Affordable Generics Act; all aspects
HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects
HR 1956 - Patient Protection and Innovative Biologic Medicines Act of 2007; all aspects
HR 2567 and S 870 - Medicare Home Infusion Therapy Consolidated Coverage Act of 2007; all aspects
HR 2606 and S 1376 - 340B Program Improvement and Integrity Act of 2007; all aspects
HR 2914 - Medicare IVIG Access Act of 2007; all aspects
HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects
HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects
HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects
HR 3193 - Access to Community Pharmacy Preservation Act of 2007; all aspects
HR 3800 - Promoting Health Information Technology Act; all aspects
HR 3932 - Medicare Prescription Drug Savings and Choice Act of 2007; all aspects
HR 4296 and S 2408 - Medicare Electronic Medication and Safety Protection (E-MEDS) Act of 2007; all aspects
H.R. 5629 - Pathway for Biosimilars Act; all aspects
S 28 - Generics First Act of 2007; all aspects
S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects
S 251 - Pharmaceutical Market Access Act of 2007; all aspects
S 273 - Prescription Drug and Health Improvement Act of 2007; all aspects
S 596 - Safe Internet Pharmacy Act of 2007; section 511(c); all aspects
S 976 - Genomics and Personalized Medicine Act of 2007; all aspects
S 980 - Online Pharmacy Consumer Protection Act of 2007; all aspects
S 1408 - Health Information Technology Act of 2007; all aspects
S 1507 - Access to Medicare Data Act of 2007; all aspects
S 1693 - Wired for Health Care Quality Act; all aspects
S 1695 - Biologics Price Competition and Innovation Act of 2007; all aspects
S. 1814 - Health Information Privacy and Security Act; all aspects
S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects
Client expense: Not reported · Firm income: $60,000
Cited source text, amounts, lobbyists, and targets
Electronic Prescribing, Pharmacy Payments, Pharmacy Antitrust Exemption, Internet Pharmacies. HR 971 and S 885 - Community Pharmacy Fairness Act of 2007; all aspects
HR 1474 - Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007; all aspects
HR 2970 - Pharmacy Benefit Manager Transparency Act of 2007; all aspects
HR 3140 - Saving Our Community Pharmacies Act of 2007; all aspects
HR 3090 - Patient and Pharmacy Protection Act of 2007; all aspects
HR 3193 Access to Community Pharmacy Preservation Act of 2007; all aspects
S 242 - Pharmaceutical Market Access and Drug Safety Act of 2007; all aspects
S 251 - Pharmaceutical Market Access Act of 2007; all aspects
S 596 - Safe Internet Pharmacy Act of 2007; section 511(c)
S 980 - Online Pharmacy Consumer Protection Act of 2007; all aspects
S 1954 - Pharmacy Access Improvement (PhAIm) Act of 2007; all aspects
S 2161 - Community Pharmacy Fairness Act of 2007; all aspects
________
Client expense: Not reported · Firm income: $60,000
Cited source text, amounts, lobbyists, and targets
H.R. 1474, Fair and Speedy Treatment (FAST) Act; S. 1954, Baucus/Grassley bill; S. 1827, Pharmacist Access and Recognition in Medicare Act of 2007; S. 3162, Children's Health and Medicare Protection Act of 2007; S. 2499, Medicare, Medicaid and SCHIP Extension Act of 2007; HR 976, Children's Health Insurance Program Reauthorization Act of 2007; S. 1954, Pharmacy Access Improvement PhAIm) Act of 2007; S. 1951, Fair Medicaid Drug Payment Act of 2007
Client expense: $928,643 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
H.R. 1474, Fair and Speedy Treatment (FAST) Act; S. 1954, Baucus/Grassley bill; S. 1827, Pharmacist Access and Recognition in Medicare Act of 2007; S. 3162, Children's Health and Medicare Protection Act of 2007; S. 2499, Medicare, Medicaid and SCHIP Extension Act of 2007; HR 976, Children's Health Insurance Program Reauthorization Act of 2007; S. 1954, Pharmacy Access Improvement PhAIm) Act of 2007; S. 1951, Fair Medicaid Drug Payment Act of 2007
Client expense: $928,643 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
Cited source text, amounts, lobbyists, and targets
HR 1663: Medicare Mental Health Modernization Act
S 1103: Helping Fill the Medicare Rx Gap Act
S 1108: Medicare Part D Outreach and Enrollment Enhancement Act S 1701: TMA/Medicare Advantage
S 1883 Accountability and Transparency in Medicare Marketing Act of 2007
S 2499 Medicare, Medicaid & SCHIP Extension Act of 2007.
S 1218 Medicare for All Act
HR 2034 Medicare for All Act
S 130 Medicare Cost Contract Extension & Retirement Act of 2007
S3 Medicare Prescription Drug Price Negotiation Act of 2007
HR 4 Medicare Prescription Drug Price Negotiation Act of 2007
HR 976 Children's Health Insurance Program Reauthorization Act of 2007
HR 971 Community Pharmacy Fairness Act of 2007
Medicare; Medicare Advantage; Medicare Part D; Comparative Effectiveness Research: HR3162 "Children's Health and Medicare
Protection Act of 2007" Section 904 only; HR2184 "Enhanced Health Care Value for All Act"; Medicare Electronic Helath Records;
Pay for Performance
S. 2785: Save Medicare Act of 2008
H.R. 4296/S. 2408: Medicare Electronic Medication and Safety Protection (E-MEDS) Act
H.R. 5613: Protecting the Medicaid Safety Net Act of 2008; Comparative Effectiveness; Medicare Reform
HR 1474 Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
HR 2567 Medicare Home Infusion Therapy Coverage Act of 2007
HR 2606 340B Program Improvement and Integrity Act of 2007
HR 2914 Medicare IVIG Access Act of 2007
HR 3932 Medicare Prescription Drug Savings and Choice Act of 2007
S 870 Medicare Home Infusion Therapy Consolidated Coverage Act of 2007
S 1376 340B Program Improvement and Integrity Act of 2007
S 1507 Access to Medicare Data Act of 2007
S 1544 Medicare Quality Enhancement Act of 2007
Competitive Bidding
Contract Disclosure Regulations
340B Program
H.R. 2945 Medicare Advantage Truth in Advertising Act
H.Con Res. 312 Budget Resolution
S. 1954 Pharmacy Access Improvement Act
S. 2408 Medicare Electronic Medication and Safety Protection Act
H.Con Res. 70 Budget Resolution
S 1893/HR 976 Children's Health Insurance Program Reauthorization Act of 2007
H.R. 3162: Children's Health and Medicare Protection Act of 2007
S. 2499 Medicare, Medicaid & SCHIP Extension Act of 2007.
Client expense: Not reported · Firm income: $75,000
Cited source text, amounts, lobbyists, and targets
H.R. 1474, Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
S. 1544, Medicare Quality Enhancement Act of 2007
S. 1951, Fair Medicaid Drug Payment Act of 2007
H.R. 3700, Fair Medicaid Drug Payment Act of 2007 S. 1954, Pharmacy Access Improvement (PhAIm) Act of 2007
Client expense: $155,000 · Firm income: Not reported
Cited source text, amounts, lobbyists, and targets
Issues pertaining to implementation of the Medicare Prescription drug benefit
HR.1474, Fair and Speedy Treatment (FAST) of Medicare Prescription Drug Claims Act of 2007
S.1827, Pharmacist Access and Recognition in Medicare (PhARM) Act of 2007
HR.3162, Children's Health and Medicare Protection Act of 2007 S.2499, Medicare, Medicaid, and SCHIP Extension Act of 2007
HR.976, Children's Health Insurance Program Reauthorization Act of 2007
S.1954, Pharmacy Access Improvement (PhAIm) Act of 2007
S.1951, Fair Medicaid Drug Payment Act of 2007
HR.3700, Fair Medicaid Drug Payment Act of 2007
HR.3140, Saving Our Community Pharmacies Act of 2007
Client expense: Not reported · Firm income: $50,000